<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
53713-0048-0
</NDCCode>
<PackageDescription>
10 TRAY in 1 CARTON (53713-0048-0) > 77 VIAL in 1 TRAY > 15 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
53713-0048-00
</NDC11Code>
<ProductNDC>
53713-0048
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Pembrolizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20140904
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
MSD International GmbH
</LabelerName>
<SubstanceName>
PEMBROLIZUMAB
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/2mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>